What is King-Devick Test?
King-Devick Technologies, Inc., operating as King-Devick Test, specializes in developing advanced assessments and monitoring tools designed to address eye movement disorders. Their core offerings include the King-Devick Test, a rapid assessment for identifying impairments in eye movements, and the King-Devick Reading Acceleration Program, aimed at improving reading fluency and comprehension. The company serves a diverse clientele, including educational institutions, healthcare professionals, and parents, with a mission to support neurological function and recovery, particularly in areas such as concussion management and reading interventions. Their approach is firmly rooted in evidence-based solutions, striving to enhance both learning and rehabilitation outcomes for individuals, including students and athletes.
How much funding has King-Devick Test raised?
King-Devick Test has raised a total of $399K across 2 funding rounds:
Debt
$150K
Debt
$249K
Debt (2020): $150K with participation from PPP
Debt (2021): $249K led by PPP
Key Investors in King-Devick Test
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for King-Devick Test?
Given King-Devick Test's position in large-scale late-stage funding, the recent strategic investment is likely to fuel significant expansion initiatives. This could involve scaling up product development, enhancing market penetration through broader distribution channels, and potentially investing in further research and development to broaden the application of their eye movement assessment technologies. The company's focus on concussion management and reading interventions suggests potential for strategic partnerships within the sports medicine, neurology, and educational technology sectors. This capital infusion is expected to solidify their market leadership and accelerate their growth trajectory.
See full King-Devick Test company page
